- Broad-Spectrum SPF 50: Provides high-level protection against both UVA and UVB rays.
- Clinically Proven Hydration: Nourishes and retains the skin’s vital moisture throughout the day.
- Micronized Titanium Dioxide: Absorbs quickly and leaves no white residue.
- Gentle on Sensitive Skin: Dermatologist tested and hypoallergenic, ideal for dry to normal, sensitive skin.
- Non-Greasy Formula: Ensures a lightweight, non-greasy feel on the skin.
- Fragrance-Free: Formulated without any added fragrances to avoid irritation.
- Non-Comedogenic: Won’t clog pores, making it suitable for everyday use.
“Tranexamic Acid Overnight Treatment (By THE INKEY LIST, 30ml)” has been added to your cart. View cart
Cetaphil Daily Facial Moisturizer with Sunscreen SPF 50 – CANADA
Rs. 4,800.00
In stock
or make 3 interest free instalments of Rs. .1,600.00 with Koko

Description
Reviews (0)
Be the first to review “Cetaphil Daily Facial Moisturizer with Sunscreen SPF 50 – CANADA” Cancel reply
Related products
Bio-Oil Hydrating Dry Skin Gel 100ml
Rs. 7,500.00or make 3 interest free instalments of Rs. .2,500.00 with Koko

YOUTH TO THE PEOPLE SUPERFOOD AIR-WHIP MOISTURE CREAM (FULL SIZE)
Rs. 9,500.00or make 3 interest free instalments of Rs. .3,166.67 with Koko

The Ordinary Niacinamide 10% + Zinc 1% (60ml)
Rs. 7,990.00or make 3 interest free instalments of Rs. .2,663.33 with Koko

MEDIK8 C-TETRA LUXE 30ML
Rs. 19,990.00or make 3 interest free instalments of Rs. .6,663.33 with Koko

The Ordinary 100% Organic Cold-Pressed Rose Hip Seed Oil (30ml)
Rs. 6,800.00or make 3 interest free instalments of Rs. .2,266.67 with Koko

Kojie San Skin Lightening Kojic Acid Soap – 135g – SINGLE BAR
Rs. 4,800.00or make 3 interest free instalments of Rs. .1,600.00 with Koko

Tranexamic Acid Overnight Treatment (By THE INKEY LIST, 30ml)
Rs. 9,800.00or make 3 interest free instalments of Rs. .3,266.67 with Koko

The Ordinary Ascorbyl Glucoside Solution 12% (30ml)
Rs. 8,990.00or make 3 interest free instalments of Rs. .2,996.67 with Koko

Reviews
There are no reviews yet.